Samsung Biologics to invest $1.5 billion to build a new factory in South Korea

SEOUL : South Korean drugmaker Samsung Biologics Co Ltd plans to invest 2 trillion won ($1.53 billion) through September 2025 to build a new factory in South Korea, the company said in a regulatory filing on Friday.

($1 = 1,304.7300 won)